[The dangers of the sudden discontinuation of drugs].
de Graeff
P A
PA
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000662:Amphetamines / Q000009:adverse effects; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001463:Barbiturates / Q000009:adverse effects; D001569:Benzodiazepines; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008094:Lithium / Q000009:adverse effects; D009294:Narcotics / Q000009:adverse effects; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D000662:Amphetamines; D014151:Anti-Anxiety Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D014150:Antipsychotic Agents; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D009294:Narcotics; D001569:Benzodiazepines; D008094:Lithium
De gevaren van het plotseling staken van geneesmiddelen.